Companies: 10,795·Total market cap: $144.5T

Abcam plc

Abcam plc

ABCZFOTCHealthcare

$22.25

+$0.15(+0.68%)

Market Cap$5.1B

P/E Ratio—

52W High$22.25

52W Low$22.25

Avg Volume65

Open$22.25

Beta0.86

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Abcam plc (ABCZF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ABCZF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.02Earnings history

PE Ratio (TTM)1308.8×PE Ratio deep dive

Revenue (TTM)$379.7MFull revenue history

Dividend Yield1.12%Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

Explore Abcam plc Data

Market Cap$5.1B

Analyst Forecast$— · Hold

Revenue$241.0M-36.12%

EarningsEPS $0.00

PE Ratio1308.8×

Financial Snapshot

Full Financials

FY 2024Revenue$241.0M▼ 36.12% YoY

202220232024

FY 2024Net Income$135.7M▲ +220.17% YoY

202220232024

FY 2024EPS$0.00

202220232024

TTM:Revenue: $379.7MNet Income: $3.9MEPS: $0.02View income statement →

Analyst Ratings & Price Target

Hold5 analysts

Strong Buy

0

Buy

1

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$22.25Current

$—Avg Target

$—High

Total: 5 · Buy rate: 20.0%

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

$22.25+0.68%$5.1B #2

ALK-Abelló A/S

$90.00+0.00%$0 #3

Alpine Immune Sciences, Inc.

$64.97+0.02%$4.5B #4

Arena Pharmaceuticals, Inc.

$99.99+0.00%$0 #5

Ascentage Pharma Group International

$4.53-3.51%$1.7B #6

CymaBay Therapeutics, Inc.

$32.48+0.03%$3.7B

Stock Performance

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.91%

YTD+46.00%

1Y+41.36%

5Y+66.92%

About Abcam plc

CEOMarkus Lusser

IPO DateApr 11, 2011

Employees1,760

CountryGB

Websiteabcam.com

Abcam plc is a prominent life sciences firm specializing in the creation, refinement, and provision of specialized agents and instruments crucial for scientific investigation, diagnostic procedures, a…

Biotechnology HealthcareOTCGB

About Stock Overview & Key Data

Abcam plc (ABCZF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 11, 2011. As of the latest trading session, ABCZF stock price is $22.25, with a market capitalization of $5.1B. The stock has returned +41.36% over the past 12 months and +46.00% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Abcam plc stock is Hold, with an average 12-month price target of $—. In fiscal year 2024, Abcam plc reported revenue of $241.0M and net income of $135.7M. For detailed data — including Abcam plc revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Abcam plc (ABCZF) stock price is $22.25. The stock is traded on OTC under the ticker symbol ABCZF. The 52-week range is $22.25 – $22.25.

ABCZF stock priceABCZF quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice